CN105412205A - Medicine for treating ascites due to cirrhosis - Google Patents
Medicine for treating ascites due to cirrhosis Download PDFInfo
- Publication number
- CN105412205A CN105412205A CN201510950424.9A CN201510950424A CN105412205A CN 105412205 A CN105412205 A CN 105412205A CN 201510950424 A CN201510950424 A CN 201510950424A CN 105412205 A CN105412205 A CN 105412205A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- cirrhosis
- ascites
- root bark
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 206010003445 Ascites Diseases 0.000 title claims abstract description 35
- 208000019425 cirrhosis of liver Diseases 0.000 title abstract description 10
- 229940079593 drug Drugs 0.000 title abstract description 6
- 206010016654 Fibrosis Diseases 0.000 title abstract description 5
- 230000007882 cirrhosis Effects 0.000 title abstract description 5
- 240000009087 Crescentia cujete Species 0.000 claims abstract description 9
- 235000005983 Crescentia cujete Nutrition 0.000 claims abstract description 9
- 235000009797 Lagenaria vulgaris Nutrition 0.000 claims abstract description 9
- 210000000582 semen Anatomy 0.000 claims description 15
- 239000002994 raw material Substances 0.000 claims description 5
- 210000004185 liver Anatomy 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 208000007232 portal hypertension Diseases 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 3
- 102000015427 Angiotensins Human genes 0.000 abstract description 2
- 108010064733 Angiotensins Proteins 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 230000003908 liver function Effects 0.000 abstract description 2
- 210000004258 portal system Anatomy 0.000 abstract description 2
- 239000003053 toxin Substances 0.000 abstract description 2
- 231100000765 toxin Toxicity 0.000 abstract description 2
- 240000001549 Ipomoea eriocarpa Species 0.000 abstract 1
- 235000005146 Ipomoea eriocarpa Nutrition 0.000 abstract 1
- 241000032989 Ipomoea lacunosa Species 0.000 abstract 1
- 241001301439 Neoshirakia japonica Species 0.000 abstract 1
- 241000594335 Pavetta Species 0.000 abstract 1
- 230000027939 micturition Effects 0.000 abstract 1
- 238000001243 protein synthesis Methods 0.000 abstract 1
- 230000008327 renal blood flow Effects 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000014616 translation Effects 0.000 abstract 1
- 239000000843 powder Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000003187 abdominal effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000521257 Hydrops Species 0.000 description 2
- 230000002016 colloidosmotic effect Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 206010041519 Spider naevus Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta (mosses)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating ascites due to cirrhosis, relates to a medicine and provides the medicine for treating ascites due to cirrhosis. The medicine is characterized by being prepared from the following traditional Chinese medicines in parts by weight: 6-30 parts of cornu bubali, 3-12 parts of black morning glory seed, 3-12 parts of white morning glory seed, 6-30 parts of Chinese aralis root bark, 6-30 parts of sapium japonicum root bark, 6-20 parts of calabash shell, 6-30 parts of herba portulacae and 6-30 parts of Stem and leaf of Hongkong Pavetta. According to the medicine, the medicines are combined and act together for exerting the functions of improving blood flow of liver and portal system, reducing portal hypertension, resisting angiotensin, increasing renal blood flow to promote urination, relax the bowels and remove toxins, improving liver function and accelerating protein synthesis, so that the purpose of quickly eliminating ascites is achieved; the clinical practice proves that the medicine for treating ascites due to cirrhosis is significant in curative effect.
Description
Technical field
The present invention relates to a kind of medicine, especially a kind of medicine for the treatment of cirrhotic ascites.
Background technology
Cirrhotic ascites, belong to the dropsy scope of the traditional Chinese medical science, the past traditional Chinese medical science thinks that dropsy is one of four large diseases, and think that distension disease is not sick then, a disease then becomes incurable disease.Modern medicine thinks that cirrhotic ascites is the result of many factors comprehensive function, it is the principal element causing ascites that portal hypertension, serum albumin reduce the colloid osmotic pressure reduction caused, Visceral artery expansion causes effective arterial circulation blood volume to decline, activate sympathetic nervous system, RAAS, causing Renal vascular to shrink, is finally cause the unbalanced reason of water and eletrolytes.The method of western medical treatment ascites, mainly controls the absorption of water and sodium salt, and application diuretic, improves plasma colloid osmotic pressure; Also just take to discharge ascites, infusion albumin, liver inside door body drainage to refractory ascites, and self concentrated ascites reinfusion etc., therapeutic effect is not obvious, Chang Fanfu or deterioration, affects the life quality of patient.
Summary of the invention
For the deficiencies in the prior art, the invention provides a kind of medicine for the treatment of cirrhotic ascites.
Technical scheme of the present invention is, a kind of medicine for the treatment of cirrhotic ascites, it is characterized in that, be made up of the raw material of Chinese medicine of following weight portion: Cornu Bubali 6-30 part, Semen Pharbitidis 3-12 part, Semen Pharbitidis 3-12 part; Cortex araliae chinensis root bark 6-30 part, white skin of Radix Sapii Radicis 6-30 part, calabash shell 6-20 part, Herba portulacae 6-30 part, Caulis et folium pavettae hongkongensis 6-30 part.
As optimization, a kind of medicine for the treatment of cirrhotic ascites of the present invention, is characterized in that: be made up of the raw material of Chinese medicine of following weight portion: Cornu Bubali 9 parts, Semen Pharbitidis 6 parts, Semen Pharbitidis 6 parts, Cortex araliae chinensis root bark 30 parts, white skin of Radix Sapii Radicis 30 parts, 9 parts, calabash shell, Herba portulacae 30 parts, Caulis et folium pavettae hongkongensis 30 parts.
The mechanism of action of ingredient of the present invention is as follows: Cornu Bubali: property picric acid is salty-cold, have the effect of heat clearing away dissipating blood stasis, obviously can shorten the bleeding time, reduce erythrocyte sedimentation rate, have excitation to hypophysis one adrenal system.
Semen Pharbitidis: property is bitter, cold, poisonous, have rush down under, diuresis, detumescence effect.
Semen Pharbitidis: property bitter cold, poisonous, have rush down under, diuresis, detumescence effect.
Cortex araliae chinensis root bark: property hardship is put down, have dissipating blood stasis for subsidence of swelling, expelling wind and removing dampness function.
White skin of Radix Sapii Radicis: property bitter cold, slightly poisonous, removing water retention by purgation, dissipating blood stasis for subsidence of swelling.
Calabash shell: property is light flat, diuretic damp eliminating.
Herba portulacae: property acid is cold, clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body.
Caulis et folium pavettae hongkongensis: sweet, light, micro-pungent, cool, the clearing away heat-damp and promoting diuresis of property.
Liver cirrhosis is the basis of disease, and ascites symptom is mark.Control ascites well, be conducive to treatment and the rehabilitation of liver cirrhosis, explore the medicine that effectively can solve ascites problem, can treat further for liver cirrhosis and precondition is provided.
The traditional Chinese medical science thinks that the etiology and pathogenesis of dropsy disease is complicated, and cold and heat and asthenia and sthenia is also deposited, and involves lung, liver,spleen,kidney four is dirty, the not all right water of lung, the dysfunction of the spleen, and liver blood deposits, and kidney water is not changed; Mend and be then jammed, attack, just hinder, control Fang Yiyong, the product that light clear matter is thin.
Advantage of the present invention: 1, lead to diaphragm dissipating blood stasis with Cornu Bubali removing heat from blood, to disappear diseases caused by retention of fluid with Semen Pharbitidis, removes hydrops between fascia with Cortex araliae chinensis root bark, with white skin of Radix Sapii Radicis, the logical three burnt hydrops of calabash shell, with Herba portulacae, Caulis et folium pavettae hongkongensis removing toxic substances yin nourishing in case just attack profit wound; 2, reached the blood flow improving liver and Portal system by drug regimen combined effect, reduce portal hypertension, opposing angiotensin, increase renal hemodynamic and diuresis catharsis and toxin expelling; Improve liver function, promote albumen synthesis, thus reach the object eliminating ascites fast.3, clinical treatment 45 example facts have proved, evident in efficacy.
Detailed description of the invention
embodiment 1: a kind of medicine for the treatment of cirrhotic ascites, is characterized in that: be made up of the raw material of Chinese medicine of following weight portion: Cornu Bubali 9 parts, Semen Pharbitidis 6 parts, Semen Pharbitidis 6 parts, Cortex araliae chinensis root bark 30 parts, white skin of Radix Sapii Radicis 30 parts, 9 parts, calabash shell, Herba portulacae 30 parts, Caulis et folium pavettae hongkongensis 30 parts.
Preparation method and step: 1, the making of Chinese herbal medicine powder.Cornu Bubali, Semen Pharbitidis, Semen Pharbitidis, calabash shell four taste are beaten powder to sieve 200 orders, make Chinese herbal medicine powder; 2, decocting liquid.Cortex araliae chinensis root bark, white skin of Radix Sapii Radicis, Herba portulacae, Caulis et folium pavettae hongkongensis are placed Chinese medicine extracting tank and decocted three times.First time adds the soak by water 2 hours into Cortex araliae chinensis root bark, white skin of Radix Sapii Radicis, Herba portulacae, Caulis et folium pavettae hongkongensis four Chinese medicine material total amount seven times of weight portions, cross leaching liquid, second time adds the soak by water one and a half hours into Cortex araliae chinensis root bark, white skin of Radix Sapii Radicis, Herba portulacae, Caulis et folium pavettae hongkongensis four Chinese medicine material total amount five times of weight portions, cross leaching liquid, third time adds the soak by water one hour into Cortex araliae chinensis root bark, white skin of Radix Sapii Radicis, Herba portulacae, Caulis et folium pavettae hongkongensis four Chinese medicine material total amount treble amount part, crosses leaching liquid; 3, powder is made.Three of step 2 medicinal liquids merged and be condensed into cream, add the Chinese herbal medicine powder of step 1, drying and crushing is sieved, and namely to obtain powder for subsequent use for 200 orders.
Usage and consumption: the present invention treats liver cirrhosis drug powder, oral 10 grams at every turn, every day three times, ante cibum taken with boiled water or ginger decoction take, within one month, be a course for the treatment of, 1-3 the course for the treatment of can be used depending on the state of an illness.
Clinical treatment is summed up: the present invention, between 1985 to 2010, uses Drug therapy patients with cirrhosis ascites 45 of the present invention example altogether.Wherein male 30 example, women 15 from; The course of disease less than 1 year 20 example, more than 1 year to 5 years 20 example, more than 5 years 5 examples; Through the inventive method treatment ascites disappearance 30 example; Basic disappearance 10; Unchanged 5; Total effective rate is 88.8%.
Model case: 1, Huang Zhe, man, 42 years old, patient was diagnosed as cirrhotic ascites before 2 years, and through therapeutic effect is not obvious repeatedly, patient examines and tells abdominal distention, weak, and inappetence has pain during hepatic region.Health check-up: chronic facies, cervical region, the visible spider angioma in front, the slight xanthochromia of sclera, have liver palm, under abdominal tympanites, liver rib not and, 2cm under spleen rib, abdominal part shifting dullness is positive, and B ultrasonic shows: portal hypertension, splenomegaly, moderate ascites.Give drug powder of the present invention treatment, each 10 grams, every day three times, 30 minutes ante cibum of morning, noon and afternoon taken with boiled water, after taking medicine 12 days, ascites alleviates, then after taking 20 days, ascites disappears substantially, advise its continue conditioning, consolidate curative effect.
2, Lee, man, 65 years old, in May, 1985 cirrhotic ascites hospitalization, treat 20 days poor effect; Find Chinese traditional treatment and go to a doctor, telling distention and fullness in the abdomen pain, inappetence, the tired power of body.Look into abdominal tympanites, epigastric vein varicose, has shifting dullness, and B ultrasonic shows: moderate ascites.Give drug powder of the present invention treatment, each 10 grams, every day three times, 30 minutes ante cibum of morning, noon and afternoon take, taken with boiled water, and after taking medicine 20 days, symptom alleviates, and advise it to continue clothes, and after treating 40 days, B ultrasonic is checked: ascites disappears substantially.Patient mental is good, and appetite is normal, advises it to continue medical treatment.
3, Cui, man, 50 years old, patient's cause inspection in 2 years found hepatitis B; See shallow complexion, limbs fatigue, hepatalgia, companion sees the slight edema of lower limb; To hospital treatment, leave hospital after alleviation.Saw before one month that abdominal part swells, inappetence myasthenia of limbs, show ascites (liver cirrhosis) through ultrasound diagnosis, give powder of the present invention treatment, take medicine one month, symptom takes a turn for the better, but ascites does not disappear completely, after advising it to take medicine one month again, and recovery from illness.
Claims (2)
1. treat a medicine for cirrhotic ascites, it is characterized in that, be made up of the raw material of Chinese medicine of following weight portion: Cornu Bubali 6-30 part, Semen Pharbitidis 3-12 part, Semen Pharbitidis 3-12 part, Cortex araliae chinensis root bark 6-30 part, white skin of Radix Sapii Radicis 6-30 part, calabash shell 6-20 part, Herba portulacae 6-30 part, Caulis et folium pavettae hongkongensis 6-30 part.
2. the medicine for the treatment of cirrhotic ascites according to claim 1, is characterized in that, is made up of the raw material of Chinese medicine of following weight portion: Cornu Bubali 9 parts, Semen Pharbitidis 6 parts, Semen Pharbitidis 6 parts, Cortex araliae chinensis root bark 30 parts, white skin of Radix Sapii Radicis 30 parts, 9 parts, calabash shell, Herba portulacae 30 parts, Caulis et folium pavettae hongkongensis 30 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510950424.9A CN105412205A (en) | 2015-12-18 | 2015-12-18 | Medicine for treating ascites due to cirrhosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510950424.9A CN105412205A (en) | 2015-12-18 | 2015-12-18 | Medicine for treating ascites due to cirrhosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105412205A true CN105412205A (en) | 2016-03-23 |
Family
ID=55491054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510950424.9A Pending CN105412205A (en) | 2015-12-18 | 2015-12-18 | Medicine for treating ascites due to cirrhosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105412205A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110917276A (en) * | 2020-01-03 | 2020-03-27 | 青岛瑞思德生物科技有限公司 | Anti-hepatic fibrosis granule and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1279074A (en) * | 2000-05-19 | 2001-01-10 | 李隆伟 | Chinese-medicinal pill 'Ganxuetong' |
| CN1720974A (en) * | 2005-05-29 | 2006-01-18 | 王福山 | Chinese medicinal composition for treating ascites due to cirrhosis |
| CN101991810A (en) * | 2009-08-25 | 2011-03-30 | 王荣春 | Medicament for treating hepatitis A and hepatitis B |
| CN103169838A (en) * | 2013-04-12 | 2013-06-26 | 严占江 | Medicine for treating hepatitis B |
| CN103656282A (en) * | 2013-11-29 | 2014-03-26 | 当涂县科辉商贸有限公司 | Traditional Chinese medicine composition for treating liver ascites |
| CN104491068A (en) * | 2014-12-21 | 2015-04-08 | 莆田市荔城区聚慧科技咨询有限公司 | Traditional Chinese medicine composition for treating liver cirrhosis |
-
2015
- 2015-12-18 CN CN201510950424.9A patent/CN105412205A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1279074A (en) * | 2000-05-19 | 2001-01-10 | 李隆伟 | Chinese-medicinal pill 'Ganxuetong' |
| CN1720974A (en) * | 2005-05-29 | 2006-01-18 | 王福山 | Chinese medicinal composition for treating ascites due to cirrhosis |
| CN101991810A (en) * | 2009-08-25 | 2011-03-30 | 王荣春 | Medicament for treating hepatitis A and hepatitis B |
| CN103169838A (en) * | 2013-04-12 | 2013-06-26 | 严占江 | Medicine for treating hepatitis B |
| CN103656282A (en) * | 2013-11-29 | 2014-03-26 | 当涂县科辉商贸有限公司 | Traditional Chinese medicine composition for treating liver ascites |
| CN104491068A (en) * | 2014-12-21 | 2015-04-08 | 莆田市荔城区聚慧科技咨询有限公司 | Traditional Chinese medicine composition for treating liver cirrhosis |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110917276A (en) * | 2020-01-03 | 2020-03-27 | 青岛瑞思德生物科技有限公司 | Anti-hepatic fibrosis granule and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100518807C (en) | A Medicine for treatment of ascites due to cirrhosis | |
| CN103007191A (en) | Chinese medicinal composition for treating jaundice | |
| CN102988656A (en) | Traditional Chinese medicine composition for treating acute pancreatitis | |
| CN103202879B (en) | Traditional Chinese medicine composition for treating chronic cardiac failure and preparation method thereof | |
| CN109966462A (en) | A kind of herbal paste and preparation method thereof improving constitution | |
| CN103006979A (en) | Chinese medicinal composition for treating nephrotic edema | |
| CN102366512A (en) | Traditional Chinese medicinal formula for treating gout | |
| CN102302733B (en) | Oral Chinese medicinal composition for treating ovarian cyst | |
| CN107308353A (en) | A kind of Chinese medicine preparation for treating diabetes | |
| CN103610936B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of coronary heart disease | |
| CN105412205A (en) | Medicine for treating ascites due to cirrhosis | |
| CN103285343A (en) | Medicine for treating liver cancer and preparation method thereof | |
| CN102935214B (en) | Traditional Chinese medicinal composition for treating uremia | |
| CN101721622A (en) | Traditional Chinese medicine for treating tension-type headache | |
| CN102988632B (en) | Chinese medicinal composition for treating oedematous | |
| CN106177163A (en) | A kind of for decoction medicine treating pruritus and preparation method thereof | |
| CN1965975A (en) | Medicinal liquid having favorable effect on the treatment of liver cirrhosis | |
| CN104758676A (en) | Medicine for treating damp-heat in resistance-type epigastric pain | |
| CN108578618A (en) | A kind of Chinese medicine composition of kidney tonifying and treatment and prevention diabetic nephropathy | |
| CN103656277B (en) | The medicine for the treatment of hepatic ascites | |
| CN102166326B (en) | Preparation method of traditional Chinese medicine for treating liver depression and kidney deficiency type hyperthyroidism | |
| CN103285360B (en) | Traditional Chinese medicinal preparation for treating thromboangiitis obliterans, and preparation method thereof | |
| CN107961355A (en) | A kind of navel ball for treating liver ascites and preparation method thereof | |
| CN102335399B (en) | Chinese medicinal composition for treating liver cirrhosis in early stage | |
| CN106344767A (en) | Traditional Chinese medicine compound for treating skin allergy and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160323 |